The global bovine lactoferrin market revenue was around US$ 410.6 million in 2023 and is estimated to reach US$ 807.2 million by 2032, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2024 to 2032.
Bovine lactoferrin is a protein found in animal milk, human milk, and other bodily fluids. Lactoferrin assists regulate how well iron is soaked into the body from the intestine. It also seems to guard against diseases from viruses, bacteria, and fungi. Bovine lactoferrin is often utilized to treat lower iron levels in pregnant ladies and to control blood infections in preterm newborns.
Market Driving Factors
The surging influence of naturally made supplements over chemical molecules among the population increases the deployment of dietary supplements with the addition of lactoferrin in both developing and developed countries. As a result, key players are progressively focusing their efforts on the fields to make a profit. Therefore, this factor is estimated to drive the market growth.
The launch of bovine lactoferrin products to fulfil customer demand in developing countries and the development of new affordable and price-effective manufacturing methods are predicted to offer numerous investment possibilities for bovine lactoferrin market expansion. For instance, in January 2024, Nuchev introduces its first bovine product targeting school-going adults and children.
The high price of lactoferrin added products to hamper the market growth.
Regional Analysis
North America dominated the market in terms of the largest shares and is estimated to maintain its dominance during the projected period. This can be primarily attributed to technological advances in manufacturing bovine lactoferrin products and the existence of key players in the region.
LAMEA is estimated to dominate the market in terms of the highest growth rate. This is due to the surging initiatives by non-profit organizations and governments to the awareness of bovine lactoferrin use and its nutritional value. Additionally, the lower rate of breastfeeding in this region is also promoting the adoption of infant formula with added lactoferrin among the population.
Segmentation Insights
Product Type Insight
The freeze-dried powder segment dominated the market in terms of revenue and is estimated to maintain its dominance during the forecast period. This can be majorly attributed to the maintenance of bifunctional properties and extended shelf life.
Application Insight
The infant nutrition segment dominates the market in terms of the rate. This is because the increase in lactoferrin powder surges the immune system's capability to combat disease.
The dietary supplement segment is estimated to dominate the market in terms of shares. This is mainly owing to the increasing concern for healthy living among the population along with the adoption of a healthy diet in the pandemic situation is boosting the adoption of natural healthy ingredients such as lactoferrin in dietary supplements.
Function Insight
The iron absorption segment dominated the market in terms of the rate and is estimated to continue its dominance. This can be majorly attributed to the number of advantages to pregnant women and the anemic population.
The immune cell stimulation segment is estimated to dominate the market in terms of the highest growth rate. This is mainly due to the potential therapeutic and prophylactic applications.
Prominent Companies
Segmentation Outline
The global bovine lactoferrin market segmentation focuses on the Product Type, Application, Function, and Region.
By Product Type
By Application
By Function
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL BOVINE LACTOFERRIN MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: BOVINE LACTOFERRIN MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL BOVINE LACTOFERRIN MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL BOVINE LACTOFERRIN MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 SPRAY DRIED POWDER
5.3 FREEZE-DRIED POWDER
6 GLOBAL BOVINE LACTOFERRIN MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DIETARY SUPPLEMENT
6.3 INFANT NUTRITION
6.3.1 DISTRIBUTION CHANNEL
6.3.1.1 ONLINE
6.3.1.2 OFFLINE
6.4 OTHERS
7 GLOBAL BOVINE LACTOFERRIN MARKET, BY FUNCTION
7.1 OVERVIEW
7.2 IRON ABSORPTION
7.3 IMMUNE CELL STIMULATION
7.4 ANTIBACTERIAL
7.5 OTHERS
8 GLOBAL BOVINE LACTOFERRIN MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL BOVINE LACTOFERRIN MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 INNER MONGOLIA YILI INDUSTRIAL GROUP CO. LTD
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 GLANBIA PLC
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 FONTERRA CO-OPERATIVE GROUP LIMITED
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 LA PROSPERITE FERMIERE SOCIETE COOPERATIVE AGRICOLE
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 SAPUTO INC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 NUTRISCIENCE INNOVATIONS LLC
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 SAVENCIA SA
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 MORINAGA & CO. LTD
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 TATUA CO-OPERATIVE DAIRY COMPANY LTD
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 BEGA CHEESE LIMITED
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 OSKIA SKINCARE LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 JARROW FORMULAS INC
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 US CLINICALS
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 SYNLAIT MILK LTD
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 BESTON GLOBAL FOOD COMPANY LTD
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 NOUMI LIMITED
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 ROYAL FRIESLAND CAMPINA N.V.
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved